Below are the most recent publications written about "Hyperlipidemias" by people in Profiles.
-
Kurth T, Rist PM, Ridker PM, Kotler G, Bubes V, Buring JE. Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women. JAMA. 2020 06 09; 323(22):2281-2289.
-
Seamon K, Sanfilippo F, Bulsara M, Roughead L, Kemp-Casey A, Bulsara C, Watts GF, Preen D. Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study. Public Health Res Pract. 2020 Mar 10; 30(1).
-
Raskind-Hood C, Saraf A, Riehle-Colarusso T, Glidewell J, Gurvitz M, Dunn JE, Lui GK, Van Zutphen A, McGarry C, Hogue CJ, Hoffman T, Rodriguez Iii FH, Book WM. Assessing Pregnancy, Gestational Complications, and Co-morbidities in Women With Congenital Heart Defects (Data from ICD-9-CM Codes in 3 US Surveillance Sites). Am J Cardiol. 2020 03 01; 125(5):812-819.
-
Ma L, Chan DC, Ooi EMM, Marcovina SM, Barrett PHR, Watts GF. Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration. J Clin Endocrinol Metab. 2019 12 01; 104(12):6247-6255.
-
Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J. 2020 01; 219:21-30.
-
Wang EQ, Bukowski JF, Yunis C, Shear CL, Ridker PM, Schwartz PF, Baltrukonis D. Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies. BioDrugs. 2019 Oct; 33(5):571-579.
-
Cote DJ, Rosner BA, Smith-Warner SA, Egan KM, Stampfer MJ. Statin use, hyperlipidemia, and risk of glioma. Eur J Epidemiol. 2019 Nov; 34(11):997-1011.
-
Stec DE, Gordon DM, Hipp JA, Hong S, Mitchell ZL, Franco NR, Robison JW, Anderson CD, Stec DF, Hinds TD. Loss of hepatic PPARa promotes inflammation and serum hyperlipidemia in diet-induced obesity. Am J Physiol Regul Integr Comp Physiol. 2019 11 01; 317(5):R733-R745.
-
Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokgözoglu L, Lewis EF. Atherosclerosis. Nat Rev Dis Primers. 2019 08 16; 5(1):56.
-
Liu Q, Matthan NR, Manson JE, Howard BV, Tinker LF, Neuhouser ML, Van Horn LV, Rossouw JE, Allison MA, Martin LW, Li W, Snetselaar LG, Wang L, Lichtenstein AH, Eaton CB. Plasma Phospholipid Fatty Acids and Coronary Heart Disease Risk: A Matched Case-Control Study within the Women's Health Initiative Observational Study. Nutrients. 2019 Jul 21; 11(7).